Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib and Dacarbazine in Metastatic Melanoma
NCT00496223Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Sep 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in melanoma, sponsored by Moffitt Cancer Center. Started Sep 2006; status: terminated.
02
Drugs
sunitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00496223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496223.